Article citationsMore>>

Yi, M., Li, A., Zhou, L., Chu, Q., Luo, S. and Wu, K. (2021) Immune Signature-Based Risk Stratification and Prediction of Immune Checkpoint Inhibitor’s Efficacy for Lung Adenocarcinoma. Cancer Immunology, Immunotherapy, 70, 1705-1719.
https://doi.org/10.1007/s00262-020-02817-z

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top